SEER News and Press, Seer Inc. From 09/20/23

2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...

REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor conferences: Morgan Stanley 21 st An...

2023-08-09 15:12:09 ET Shares of Seer (NASDAQ: SEER) were down more than 29% as of 2:45 p.m. Wednesday after the company reported second-quarter earnings after the markets closed on Tuesday. The stock is down more than 44% so far this year. Seer is a life sciences company that s...

2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...

2023-08-08 22:23:10 ET Seer, Inc. (SEER) Q2 2023 Earnings Conference Call August 08, 2023 04:30 PM ET Company Participants Carrie Mendivil - Investor Relations Omid Farokhzad - Chief Executive Officer, President & Chair David Horn - Chief Financial Officer ...

2023-08-08 16:43:22 ET Seer press release ( NASDAQ: SEER ): Q2 GAAP EPS of -$0.37 beats by $0.04 . Revenue of $4M (+11.1% Y/Y) misses by $1.07M . Expects full year 2023 revenue to be in the range of $16 million to $18 million. Ended the quarter with $396 mi...

REDWOOD CITY, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2023. Recent Highlights Achieved revenue of $...

REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 43 rd Annual Growth Conference ...

REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter of 2023 after market close on Tuesday, August 8...

2023-07-12 14:09:52 ET Summary Seer sells an integrated proteomics analysis system to biopharma firms and academic researchers. The firm's revenue growth is high from a small base and it is generating high and worsening operating losses. With sales cycles lengthening, I'm Neut...